Related Experiment Video
Updated: Aug 30, 2026

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
Published on: March 7, 2022
p53 down-regulation: a new molecular mechanism involved in ischaemic preconditioning
Mihaela M Mocanu1, Derek M Yellon
1The Hatter Institute and Centre for Cardiology, University College London Medical School, London WC1E 6DB, UK.
Abstract:
Ischaemic preconditioning is associated with the activation of prosurvival mechanisms. Here we demonstrate that following a preconditioning protocol, the proapoptotic p53 is inactivated possibly via phosphatidylinositol 3-kinase (PI3K)-protein kinase B (Akt)-murine double minute 2 (Mdm2) phosphorylation. Our data show that in preconditioned hearts Mdm2 was significantly phosphorylated, and wortmannin (a PI3K inhibitor) abrogated this effect (Western blotting). Also in preconditioned hearts p53 was shown to be bound to phospho-Mdm2 (co-immunoprecipitation). Furthermore, pifithrin alpha (a p53 inhibitor), administered to isolated perfused hearts prior to ischaemia, significantly attenuated the infarction. In conclusion our results suggest that p53 is implicated in ischaemia/reperfusion injury and that preconditioning counterbalances this effect via PI3K-Akt-Mdm2 phosphorylation.
Insights
Ischaemic preconditioning inactivates proapoptotic p53 via PI3K-Akt-Mdm2 phosphorylation, protecting hearts from ischaemia/reperfusion injury. This pathway activation is key to understanding cardioprotection during heart attacks.
Area of Science:
- Cardiovascular Science
- Molecular Biology
- Cellular Signaling
Background:
- Ischaemic preconditioning activates prosurvival pathways in the heart.
- The role of the proapoptotic protein p53 in myocardial infarction is not fully understood.
Purpose of the Study:
- To investigate the mechanism by which ischaemic preconditioning protects the heart.
- To determine the role of p53 inactivation in preconditioning-mediated cardioprotection.
Main Methods:
- Western blotting to detect Mdm2 phosphorylation.
- Co-immunoprecipitation to assess p53 binding to phospho-Mdm2.
- Assessment of infarct size in isolated perfused hearts treated with pifithrin alpha.
Main Results:
- Ischaemic preconditioning led to significant Mdm2 phosphorylation in heart tissue.
- Wortmannin, a PI3K inhibitor, blocked Mdm2 phosphorylation.
- p53 was found to bind to phospho-Mdm2 in preconditioned hearts.
- Pifithrin alpha significantly reduced infarct size in isolated perfused hearts.
Conclusions:
- p53 plays a role in ischaemia/reperfusion injury.
- Ischaemic preconditioning counterbalances p53-mediated apoptosis through PI3K-Akt-Mdm2 phosphorylation.
- Targeting the PI3K-Akt-Mdm2 pathway may offer therapeutic benefits for myocardial infarction.
Related Concept Videos
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
